Ad
related to: what is aliskiren used for in women
Search results
Results From The WOW.Com Content Network
Aliskiren (brand names Tekturna and Rasilez) is the first in a class of drugs called direct renin inhibitors. It is used for essential (primary) hypertension . [ 2 ] While used for high blood pressure, other better studied medications are typically recommended due to concerns of higher side effects and less evidence of benefit.
Aliskiren/hydrochlorothiazide, sold under the brand name Tekturna HCT among others, is a fixed-dose combination medication for the treatment of hypertension ...
Aliskiren, the third-generation renin inhibitor. Aliskiren, an orally active non-peptide renin inhibitor, was the first drug in its class on the market. It is used to treat hypertension as monotherapy or in combination with other antihypertensive agents. [7] [39] The key to the discovery of aliskiren was crystallography and molecular modeling ...
1. Better Love Butterfly. Best Overall Sex Toy. Made for solo or partner use, this vibrator is a top seller. The handle shape makes it super easy to maneuver and it has ten vibration modes with ...
Women are often concerned about the safety of antihypertensives and as a result, many do not take their treatment as prescribed. Shared decision-making aids have been shown to reduce women's uncertainty about taking antihypertensives and increase the number of women taking them as prescribed.
The simply 'nostalgic' sandwich that Harrison Ford used to always make for his son. Food. Delish. The 66 best winter soups to warm you up all season long. Lighter Side. Lighter Side. Parade.
67 Best Gifts for Women That'll Make Her Smile. The Best Pillows for Every Type of Sleeper. Show comments. Advertisement. Advertisement. In Other News. Entertainment. Entertainment. People.
[1] [2] It contains aliskiren, a renin inhibitor; amlodipine, as the besylate, a calcium channel blocker; and hydrochlorothiazide, a thiazide diuretic. [1] It is taken by mouth. [1] It was approved for medical use in the United States in December 2010. [1] [3] [4] Amturnide was withdrawn by Novartis from the US market in 2017. [5]